Neurons in vulnerable regions of the Alzheimer's disease brain display reduced ATM signaling

eNeuro

Volumn 3, Issue 1, 2016, Pages 167-179

  Shen, Xuting ^a,b   Chen, Jianmin ^c   Li, Jiali ^d   Kofler, Julia ^e   Herrup, Karl ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c RUTGERS UNIVERSITY   (United States)

^d KUNMING INSTITUTE OF ZOOLOGY   (China)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; HISTONE DEACETYLASE 4; PRESENILIN 1; ATM PROTEIN, HUMAN; ATM PROTEIN, MOUSE; HDAC4 PROTEIN, HUMAN; HDAC5 PROTEIN, MOUSE; HISTONE DEACETYLASE; REPRESSOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA TELANGIECTASIA; CELL PROLIFERATION ASSAY; DNA REPLICATION; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING; ANIMAL; BRAIN; C57BL MOUSE; CELL CYCLE; CELL NUCLEUS; DISEASE MODEL; ENZYMOLOGY; FEMALE; GENETICS; MALE; METABOLISM; NERVE CELL; PATHOLOGY; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; ANIMALS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; BRAIN; CELL CYCLE; CELL NUCLEUS; DISEASE MODELS, ANIMAL; FEMALE; HISTONE DEACETYLASES; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION;

EID: 85010243158     PISSN: None     EISSN: 23732822     Source Type: Journal    
DOI: 10.1523/ENEURO.0124-15.2016     Document Type: Article

References (55)

1. Arendt T (2009) Synaptic degeneration in Alzheimer’s disease. Acta Neuropathol 118: 167-179. CrossRef Medline
2. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cereb Cortex 1: 103-116. Medline
3. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wynshaw-Boris A (1996) Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86: 159-171. Medline
4. Barlow C, Brown K, Deng C, Tagle D, Wynshaw-Boris A (1997) Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways. Nat Genet 17: 453-456. CrossRef Medline
5. Braak H, Braak E (1991) Neuropathological stageing of Alzheimerrelated changes. Acta Neuropathol 82: 239-259. Medline
6. Braak H, Del Tredici K (2011) The pathological process underlying Alzheimer’s disease in individuals under thirty. Acta Neuropathol 121: 171-181. CrossRef Medline
7. Busser J, Geldmacher DS, Herrup K (1998) Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer’s disease brain. J Neurosci 18: 2801-2807. Medline
8. Caruana DA, Alexander GM, Dudek SM (2012) New insights into the regulation of synaptic plasticity from an unexpected place: hippocampal area CA2. Learn Mem 19: 391-400. CrossRef Medline
9. Chevaleyre V, Siegelbaum SA (2010) Strong CA2 pyramidal neuron synapses define a powerful disynaptic cortico-hippocampal loop. Neuron 66: 560-572. CrossRef Medline
10. Copani A, Uberti D, Sortino MA, Bruno V, Nicoletti F, Memo M (2001) Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path? Trends Neurosci 24: 25-31. Medline
11. Coyle JT, Price DL, DeLong MR (1983) Alzheimer’s disease: a disorder of cortical cholinergic innervation. Science 219: 1184-1190. Medline
12. Cui CM, Gao JL, Cui Y, Sun LQ, Wang YC, Wang KJ, Li R, Tian YX, Cui JZ (2015) Chloroquine exerts neuroprotection following traumatic brain injury via suppression of inflammation and neuronal autophagic death. Mol Med Rep 12: 2323-2328. CrossRef Medline
13. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity. Ann Neurol 27: 457-464. CrossRef Medline
14. Deng QS, Dong XY, Wu H, Wang W, Wang ZT, Zhu JW, Liu CF, Jia WQ, Zhang Y, Schachner M, Ma QH, Xu RX (2016) Disrupted-inschizophrenia-1 attenuates amyloid-beta generation and cognitive deficits in APP/PS1 transgenic mice by reduction of beta-site APP-cleaving enzyme 1 levels. Neuropsychopharmacology 41: 440-453.
15. Godyń J, Jończyk J, Panek D, Malawska B (2016) Therapeutic strategies for Alzheimer’s disease in clinical trials. Pharmacol Rep 68: 127-138. CrossRef Medline
16. Hanseeuw BJ, Van Leemput K, Kavec M, Grandin C, Seron X, Ivanoiu A (2011) Mild cognitive impairment: differential atrophy in the hippocampal subfields. AJNR Am J Neuroradiol 32: 1658-1661. CrossRef Medline
17. Herrup K, Li J, Chen J (2013) The role of ATM and DNA damage in neurons: upstream and downstream connections. DNA Repair (Amst) 12: 600-604. CrossRef Medline
18. Hitti FL, Siegelbaum SA (2014) The hippocampal CA2 region is essential for social memory. Nature 508: 88-92. CrossRef Medline
19. Hui CW, Herrup K (2015) Individual cytokines modulate the neurological symptoms of ATM deficiency in a region specific manner( 1,2,3). eNeuro 2. CrossRef Medline
20. Ideno Y, Takayama M, Hayashi K, Takagi H, Sugai Y (2012) Evaluation of a Japanese version of the Mini-Mental State Examination in elderly persons. Geriatr Gerontol Int 12: 310-316. CrossRef Medline
21. Joachim CL, Morris JH, Selkoe DJ (1989) Diffuse senile plaques occur commonly in the cerebellum in Alzheimer’s disease. Am J Pathol 135: 309-319. Medline
22. Khanna KK (2000) Cancer risk and the ATM gene: a continuing debate. J Natl Cancer Inst 92: 795-802. Medline
23. Lamb BT, Bardel KA, Kulnane LS, Anderson JJ, Holtz G, Wagner SL, Sisodia SS, Hoeger EJ (1999) Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice. Nat Neurosci 2: 695-697. CrossRef Medline
24. Lavin MF, Kozlov S (2007) ATM activation and DNA damage response. Cell Cycle 6: 931-942. Medline
25. Li J, Chen J, Vinters HV, Gatti RA, Herrup K (2011a) Stable brain ATM message and residual kinase-active ATM protein in ataxiatelangiectasia. J Neurosci 31: 7568-7577. CrossRef Medline
26. Li J, Chen J, Ricupero CL, Hart RP, Schwartz MS, Kusnecov A, Herrup K (2012) Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia. Nat Med 18: 783-790. CrossRef Medline
27. Li J, Hart RP, Mallimo EM, Swerdel MR, Kusnecov AW, Herrup K (2013) EZH2-mediated H3K27 trimethylation mediates neurodegeneration in ataxia-telangiectasia. Nat Neurosci 16: 1745-1753. CrossRef Medline
28. Li L, Cheung T, Chen J, Herrup K (2011b) A comparative study of five mouse models of Alzheimer’s disease: cell cycle events reveal new insights into neurons at risk for death. Int J Alzheimers Dis 2011: 171464. CrossRef Medline
29. Lim AC, Qi RZ (2003) Cyclin-dependent kinases in neural development and degeneration. J Alzheimers Dis 5: 329-335. Medline
30. Mankin EA, Diehl GW, Sparks FT, Leutgeb S, Leutgeb JK (2015) Hippocampal CA2 activity patterns change over time to a larger extent than between spatial contexts. Neuron 85: 190-201. Cross-Ref Medline
31. McKeith IG, et al. (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65: 1863-1872. CrossRef Medline
32. McShea A, Harris PL, Webster KR, Wahl AF, Smith MA (1997) Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer’s disease. Am J Pathol 150: 1933-1939. Medline
33. Nagy Z, Esiri MM, Cato AM, Smith AD (1997) Cell cycle markers in the hippocampus in Alzheimer’s disease. Acta Neuropathol 94: 6-15. CrossRef
34. Nagy Z (2005) The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer’s disease. J Cell Mol Med 9: 531-541. Medline
35. Nguyen MD, Mushynski WE, Julien JP (2002) Cycling at the interface between neurodevelopment and neurodegeneration. Cell Death Differ 9: 1294-1306. CrossRef Medline
36. Ochiishi T, Saitoh Y, Yukawa A, Saji M, Ren Y, Shirao T, Miyamoto H, Nakata H, Sekino Y (1999) High level of adenosine A1 receptor-like immunoreactivity in the CA2/CA3a region of the adult rat hippocampus. Neuroscience 93: 955-967. Medline
37. Park DS, Levine B, Ferrari G, Greene LA (1997) Cyclin dependent kinase inhibitors and dominant negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons. J Neurosci 17: 8975-8983. Medline
38. Querfurth HW, LaFerla FM (2010) Alzheimer’s disease. N Engl J Med 362: 329-344. CrossRef Medline
39. Schneider JG, Finck BN, Ren J, Standley KN, Takagi M, Maclean KH, Bernal-Mizrachi C, Muslin AJ, Kastan MB, Semenkovich CF (2006) ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab 4: 377-389. CrossRef Medline
40. Schröder H, Giacobini E, Struble RG, Zilles K, Maelicke A (1991) Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer’s disease. Neurobiol Aging 12: 259-262. Medline
41. Shiloh Y, Rotman G (1996) Ataxia-telangiectasia and the ATM gene: linking neurodegeneration, immunodeficiency, and cancer to cell cycle checkpoints. J Clin Immunol 16: 254-260. Medline
42. Smith TW, Lippa CF (1995) Ki-67 immunoreactivity in Alzheimer’s disease and other neurodegenerative disorders. J Neuropathol Exp Neurol 54: 297-303. Medline
43. Wegiel J, Wisniewski HM, Dziewiatkowski J, Badmajew E, Tarnawski M, Reisberg B, Mlodzik B, De Leon MJ, Miller DC (1999) Cerebellar atrophy in Alzheimer’s disease-clinicopathological correlations. Brain Res 818: 41-50. Medline
44. Williams GC (1957) Pleiotropy, natural selection, and the evolution of senescence. Evolution 11: 398-411. CrossRef
45. Wolf DS, Gearing M, Snowdon DA, Mori H, Markesbery WR, Mirra SS (1999) Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. Alzheimer Dis Assoc Disord 13: 226-231. Medline
46. Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Nakazato Y (1989) Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain. Acta Neuropathol 77: 314-319. Medline
47. Yang Y, Geldmacher DS, Herrup K (2001) DNA replication precedes neuronal cell death in Alzheimer’s disease. J Neurosci 21: 2661-2668. Medline
48. Yang Y, Mufson EJ, Herrup K (2003) Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer’s disease. J Neurosci 23: 2557-2563. Medline
49. Yang Y, Herrup K (2005) Loss of neuronal cell cycle control in ataxia-telangiectasia: a unified disease mechanism. J Neurosci 25: 2522-2529. CrossRef Medline
50. Yang Y, Varvel NH, Lamb BT, Herrup K (2006) Ectopic cell cycle events link human Alzheimer’s disease and amyloid precursor protein transgenic mouse models. J Neurosci 26: 775-784. Cross-Ref Medline
51. Yang Y, Herrup K (2007) Cell division in the CNS: protective response or lethal event in post-mitotic neurons? Biochim Biophys Acta 1772: 457-466. CrossRef Medline
52. Yang Y, Hui CW, Li J, Herrup K (2014) The interaction of the atm genotype with inflammation and oxidative stress. PLoS One 9: e85863. CrossRef Medline
53. Young WS, Li J, Wersinger SR, Palkovits M (2006) The vasopressin 1b receptor is prominent in the hippocampal area CA2 where it is unaffected by restraint stress or adrenalectomy. Neuroscience 143: 1031-1039. CrossRef Medline
54. Zweig RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ, Folstein MF, Price DL (1988) The neuropathology of aminergic nuclei in Alzheimer’s disease. Ann Neurol 24: 233-242. CrossRef Medline
55. Zweig RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ, Folstein MF, Price DL (1989) Neuropathology of aminergic nuclei in Alzheimer’s disease. Prog Clin Biol Res 317: 353-365. Medline